Banque Cantonale Vaudoise’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Banque Cantonale Vaudoise’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,200	Closed	-$50K	–	1085
2023 Q4	$50K	Hold	1,200	–	–	﹤0.01%	805
2023 Q3	$48K	Hold	1,200	–	–	﹤0.01%	974
2023 Q2	$49K	Hold	1,200	–	–	﹤0.01%	967
2023 Q1	$49K	Hold	1,200	–	–	﹤0.01%	964
2022 Q4	$49K	Hold	1,200	–	–	﹤0.01%	961
2022 Q3	$48K	Hold	1,200	–	–	﹤0.01%	998
2022 Q2	$50K	Hold	1,200	–	–	﹤0.01%	1005
2022 Q1	$54K	Hold	1,200	–	–	﹤0.01%	1033
2021 Q4	$55K	Hold	1,200	–	–	﹤0.01%	1054
2021 Q3	$57K	Hold	1,200	–	–	﹤0.01%	1027
2021 Q2	$62K	Hold	1,200	–	–	﹤0.01%	1024
2021 Q1	$60K	Hold	1,200	–	–	﹤0.01%	979
2020 Q4	$62K	Hold	1,200	–	–	﹤0.01%	915
2020 Q3	$52K	Buy	+1,200	New	+$52.6K	﹤0.01%	904

Other funds holding XPH

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Banque Cantonale Vaudoise's XPH Position: Q1 2024 in Review

Banque Cantonale Vaudoise sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2024, closing a stake of 1,200 shares — an estimated $50K sold.

Banque Cantonale Vaudoise first reported a position in XPH in Q3 2020 and held it in 14 quarters. The position peaked at $62K in Q2 2021. 73 funds tracked by Wall St. Rank hold XPH as of Q1 2024.

Banque Cantonale Vaudoise reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2024 after selling out during the quarter.
Banque Cantonale Vaudoise sold 1,200 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2024, an estimated $50K.
Banque Cantonale Vaudoise first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2020 and held it in 14 quarters.
Banque Cantonale Vaudoise's State Street SPDR S&P Pharmaceuticals ETF position peaked at $62K in Q2 2021.
73 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2024.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2024, filed 10 Apr 2024.